Pharma's Almanac | First-in-Class Drugs

3 Articles Available

FDA New Drug Approvals

Many First-in-Class Drugs Approved by FDA in 2022, but Overall Approval Numbers Down

PAO-03-23-NI-03

Drug Development

Novartis Licenses First-in-Class Heart Disease Drug

PAO-M03-19-NI-008

FDA Analysis

FDA Analysis Shows Reduced Competition for First-in-Class Drugs

PAO-M08-18-NI-002